Fundz

Pinetree Therapeutics, Inc. Secures $23.5 Million Of Series A1 Funding To Develop Cutting Edge Platform Technology To Create Therapeutic Assets For Unmet Medical Needs

PRIVATEJun 07, 2022

Amount Raised

$23.5 Million

Round Type

Series A

CambridgeBiotechnologyHealth CareScience And Engineering

Description

PineTree Therapeutics, Inc., an emerging leader in pioneering the development of disruptive therapies in Oncology, Immuno-oncology and other diseases, announced that the company has raised $23.5 Million for Series A1 funding. The investments, which will be used to advance our Oncology and Viral Diseases platforms, were made by InterVest, SK Securities, DSC Investment, J Curve Investment, Samho Green Investment, and SJ Investment Partners.

Quick answer

PineTree Therapeutics raised $23.5 Million in a Series A round, dated June 7, 2022. PineTree Therapeutics is based in Cambridge, Massachusetts, United States.

How much did PineTree Therapeutics raise?
PineTree Therapeutics raised $23.5 Million in a Series A round on June 7, 2022.
What does PineTree Therapeutics do?
Pinetree Therapeutics, based in Cambridge, MA, is a preclinical-stage biotech company developing next-generation targeted protein degraders (TPDs) to overcome drug resistance and tumor recurrence in oncology, with..
Where is PineTree Therapeutics based and how big is it?
PineTree Therapeutics is based in Cambridge, Massachusetts, United States. Fundz records about 36 employees.
Who are the decision-makers at PineTree Therapeutics?
Fundz holds 1 contact at PineTree Therapeutics, including the CEO/Founder. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Science And Engineering and Biotechnology around the same time

Companies in the same sectors as PineTree Therapeutics that raised within 45 days of this round, from Fundz verified event records.

  • Trait Biosciences Inc. raised $102K (Series A) on July 22, 2022.
  • Enveric Biosciences raised $8.6M on July 22, 2022.
  • 22nd Century raised $35M on July 21, 2022.
  • Camp4 Therapeutics Corp raised $100M (Series B) on July 20, 2022.
  • Agomab raised $41M (Series B) on July 13, 2022.
  • Advanced NanoTherapies raised $7.2M (Series A) on June 28, 2022.

Who to call at PineTree Therapeutics, and when

A new round usually means PineTree Therapeutics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day PineTree Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at PineTree Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at PineTree Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

PineTree Therapeutics

Location

767 Concord Ave

Cambridge, Massachusetts, United States

About

Pinetree Therapeutics, based in Cambridge, MA, is a preclinical-stage biotech company developing next-generation targeted protein degraders (TPDs) to overcome drug resistance and tumor recurrence in oncology, with applications in inflammation and immunology. Its proprietary AbReptor™ platform enables selective degradation of membrane-bound and extracellular proteins, offering a differentiated mechanism of action and durable therapeutic benefit. Pinetree is also advancing trispecific degraders and ADC-integrated platforms, and has entered strategic partnerships, including a licensing agreement with AstraZeneca.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment PineTree Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsHo-Juhn S., CEO/Founder hidden hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for PineTree Therapeutics's next move

See what Strategic adds

Funding Insights

What this usually means
Typical timeline to Series B
Series A companies typically raise their next round in 10-18 months

PineTree Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.